Article Sidebar

Submitted
Apr 24, 2021
Published
Apr 24, 2021
Download
PDF
Statistic
Read Counter : 60 Download : 35

Main Article Content

Abstract

AIM & OBJECTIVES


The study investigated the level of drug adherence among hypertensive patients at a tertiary care hospital in Erode, Tamil Nadu. Specific objectives included measurement of blood pressure (BP) control achievement, estimating prevalence of drug adherence behaviour, and establishing the association between drug adherence behaviour and achievement of BP control.


METHODS AND MATERIALS


A question based observational study was carried out for 6 months with 102 participants.


FINDINGS


From the total number of subjects, majority were females (n =56; 54.9%). Out of the 102 patients, 40.2% (n = 41) of them were found to be medication adherent and 59.8% (n = 61) were non adherent. Blood pressure control was achieved in 70.7% (n = 29) among adherent patients while BP control was only 39.3% (n = 24) in non adherent patients.


CONCLUSION


From this study it can be concluded that medication adherence is very much important for blood pressure control. Poor drug adherence behaviour prevails among hypertensive patients and it can lead to poor achievement of blood pressure control. Thus this study shows an importance of regular patient counselling and awareness programme for improving medication adherence.

Keywords

Blood pressure non adherence patient education

Article Details

How to Cite
Sagarika BH, Arun Mathew, Sattanathan K, & Sambathkumar R. (2021). Medication Adherence Pattern Of Hypertensive Patients In Rural Area. International Journal of Research in Pharmacology & Pharmacotherapeutics, 4(4), 382-387. https://doi.org/10.61096/ijrpp.v4.iss4.2015.382-387
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Haynes RB, Sackett DL (1976) Compliance with therapeutic regimens: Johns Hopkins University Press.
  2. [2]. Sabate E, World Health Organization, WHO. Adherence to Long Term Therapies Project, Global Adherence Interdisciplinary Network (2003) Adherence to long-term therapies: evidence for action. Geneva: World Health Organization. xv, 198p.
  3. [3]. Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, MA: Little, Brown; 1994
  4. [4]. Kearney PM, Whelton M, Reynolds K. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455): 217–223.
  5. [5]. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006; 24: 423–30.
  6. [6]. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665.
  7. [7]. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey. Hypertension. 1995; 25: 305–13.
  8. [8]. Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients? J Cardiovasc Pharmacol. 2000; 35(Suppl 3): S23–6.
  9. [9]. Herttua K, Tabak AG, Martikainen P, Vahtera J, Kivimaki M. Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study. Eur Heart J.2013; 34: 2933–9.
  10. [10]. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34: 2159–219.
  11. [11]. Isaza CA, Moncada JC, Mesa G, Osorio FJ. Effectiveness of treatments for hypertension in a sample of Colombian patients. Biomedica. 3: 273–281.
  12. [12]. Ruppar TM, Dobbels F, De Geest S. Medication beliefs and antihypertensive adherence among older adults: a pilot study. Geriatr Nurs. 2: 89–95.
  13. [13]. Lerner AG, Bernabe-Ortiz A, Gilman RH, Smeeth L, Miranda JJ (2013) The “rule of halves” does not apply in Peru: awareness, treatment, and control of hypertension and diabetes in rural, urban, and rural-to-urban migrants. Crit Pathw Cardiol 2: 53–58.
  14. [14]. Jonas JB, Nangia V, Matin A, Joshi PP, Ughade SN. Prevalence, awareness, control, and associations of arterial hypertension in a rural central India population: the Central India Eye and Medical Study. Am J Hypertens. 2010; 23: 347–50.
  15. [15]. Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities Am J Kidney Dis. 2010; 55: 590–8.
  16. [16]. Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens. 2004;18:545–51.
  17. [17]. Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW. Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension. J Hum Hypertens.2007; 21: 99–106.
  18. [18]. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008; 118: 2679–86.
  19. [19]. Herttua K, Tabak AG, Martikainen P, Vahtera J, Kivimaki M. Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study. Eur Heart J. 2013; 34: 2933–9.
  20. [20]. Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol. 2008; 128: 392–8.